Alberto Jose Sancho Piedrahita currently serves as the Head of Global Vaccine Business at Viatris, a pivotal role that underscores his extensive expertise in commercial and brand management within the pharmaceutical industry. Following the strategic integration of Mylan and Upjohn, Alberto has been instrumental in...
Alberto Jose Sancho Piedrahita currently serves as the Head of Global Vaccine Business at Viatris, a pivotal role that underscores his extensive expertise in commercial and brand management within the pharmaceutical industry. Following the strategic integration of Mylan and Upjohn, Alberto has been instrumental in shaping the global marketing landscape for vaccines, particularly focusing on the influenza vaccine segment. His responsibilities encompass the design of comprehensive marketing strategies and the tactical implementation of these initiatives across diverse markets, including all EU countries, Australia, and Canada.
Under Alberto's leadership, Viatris is not only enhancing its vaccine portfolio but also driving innovative approaches to product launches in both retail and hospital settings. His deep understanding of pharmaceutical sales and sales force effectiveness allows him to optimize performance and ensure that the company's offerings meet the evolving needs of healthcare providers and patients alike. With a strong foundation in strategic planning and marketing, Alberto is adept at navigating the complexities of the global healthcare environment, ensuring that Viatris remains at the forefront of vaccine accessibility and efficacy.
Alberto's expertise extends beyond vaccines; his background in gastroenterology and biotechnology enriches his strategic vision, enabling him to leverage cross-functional insights that enhance product positioning and market penetration. His commitment to excellence in pharmaceutical marketing and business administration positions him as a key player in the ongoing evolution of vaccine distribution and public health initiatives, ultimately contributing to improved health outcomes on a global scale.
